ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific ...

A naturopathic case exploring how structured somatic medicine can support nervous system regulation, emotional processing, ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing in ...

West Nile virus is the leading mosquito-borne infection in the United States. Neuroinvasive disease affects less than 1% but it can be fatal.

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Employment rates for patients with end-stage kidney disease were higher for those with access to home hemodialysis or evening ...

Therapeutics announced that the first patient has been dosed in a Phase 2 clinical trial of praliciguat, an oral, once-daily ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

Rojo, the 19-year-old Sumatran tiger at Miller Park Zoo, was humanely euthanized due to his declining condition from renal ...

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

We are pleased by the timely initiation of this important Phase 2 clinical trial of praliciguat and have successfully dosed the first patient following the defined screening process,” said Dr. Steven ...

44 th Annual J.P. Morgan Healthcare Conference Date: Wednesday, January 14, 2026 Time: 8:15am PST Format: Presentation Webcast: Link ...